Mounjaro®
Starting from £179.99/mo
Start journey Learn moreCombining Mounjaro and intermittent fasting is not dangerous for most people, but it is probably unnecessary for the majority — and for some, it makes side effects worse. Tirzepatide already shifts your appetite biology significantly, so adding a rigid eating window on top can work well or backfire depending on how your body is responding to treatment. These are prescription-only medicines, and any major change to your eating pattern alongside them is worth discussing with your prescriber first.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misconception our prescribers come across is that intermittent fasting on Mounjaro accelerates results, that skipping breakfast or running a 16:8 window somehow amplifies what the medicine does. It is an appealing idea, but the clinical evidence does not back it up.
Mounjaro works by activating two gut-hormone receptors, GIP and GLP-1, that regulate appetite, slow the rate food leaves the stomach and improve how your body handles blood sugar. The result is that most people on tirzepatide feel full much sooner and stay full much longer. In SURMOUNT-1, participants on the 15mg dose lost around 20–21% of body weight on average over 72 weeks, eating a reduced-calorie diet, not a fasting protocol. No arm of the SURMOUNT programme tested intermittent fasting alongside tirzepatide, so any claim about the combination producing greater loss than the medicine alone is speculation. What the SURMOUNT-1 trial, published in the New England Journal of Medicine, shows is that tirzepatide itself produces substantial, sustained weight loss when paired with a sensible calorie-reduced diet and more activity, which is precisely what the licence says.
In practice, some people find they are naturally eating within a shorter daily window once treatment begins, simply because appetite drops sharply and they no longer feel hungry in the morning. That is not the same as deliberately imposing a fasting schedule. The distinction matters.
Tirzepatide's most common side effects are gastrointestinal: nausea, queasiness, loose stools, reflux and occasional vomiting. The NHS tirzepatide patient information page notes these are most noticeable after starting treatment or after a dose increase, and typically ease within a few days to a couple of weeks.
Running a long fasting window in those early weeks stacks another metabolic stress on top of an already unsettled system. Low blood sugar, light-headedness and fatigue are more likely if you are going 18 or 20 hours without eating while your body is simultaneously adapting to a medicine that slows gastric emptying. For people who had skipped breakfast comfortably before treatment, the same habit can feel very different once tirzepatide is on board, the stomach simply empties more slowly, so eating too soon before a long gap can cause prolonged nausea.
There is also the protein question. Muscle mass loss is a recognised concern during significant weight loss. Tirzepatide does not protect against it automatically; adequate daily protein does. Compressing all eating into a 6 or 8-hour window makes it genuinely harder to hit a reasonable protein target, particularly when appetite is already suppressed. If you want to read more about what to prioritise on the plate, our guide on what to eat on Mounjaro covers practical food choices in more detail, including protein sources that tend to sit well during treatment.
Rather than a rigid fasting schedule, what actually complements tirzepatide is eating in a way that supports the medicine's appetite effects without fighting them. That means eating when you are genuinely hungry, stopping when full (the medicine makes that signal much clearer than before), prioritising protein and fibre at each meal, and staying well hydrated.
Some people find that eating two or three smaller meals rather than three large ones works well, especially in the first few months. Others find that a light, protein-forward breakfast helps prevent the nausea that can come from taking tirzepatide completely on an empty stomach, though the pen itself is injected subcutaneously, not taken orally, so food timing around the dose is less critical than with oral medicines. Keeping the pen in the fridge door where you will notice it on a regular day is a simple habit that helps; the injection can be done in the morning or evening as long as you stick to the same day each week.
For a closer look at how fasting windows interact with tirzepatide day to day, this dedicated page on fasting on tirzepatide goes further into the practical questions. There is also more detail at fasting on Mounjaro for people who are already following an eating schedule and want to know whether to keep it going. If water fasting specifically is something you are considering, water fasting on Mounjaro is worth reading first.
Intermittent fasting is not inherently incompatible with Mounjaro. Some people do combine them without issue, particularly those who have followed a mild 12:12 or 14:10 pattern for years and find it genuinely sustainable. The important point is that the approach is discussed with a clinician who knows your dose, your side-effect history and your other health conditions.
If you are thinking about Mounjaro as part of a broader weight-management approach, the starting point is a clinical assessment, not a fasting plan. The Mounjaro treatment overview explains the full licensed indication and who it suits. If cost is part of your decision-making, our Mounjaro price page sets out what private treatment involves and what is typically included. And if you have already started treatment and want to explore how your eating pattern fits, speaking to your prescriber is the right first step. At nume, a real clinician reads your consultation the same day, not software.
You can also explore the broader range of weight-loss treatment options if you are still deciding which route fits. Speak to our prescribers to discuss whether Mounjaro is appropriate for you and how best to structure your diet alongside it.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.